The novel role of Micro T-Wave alternans in arrhythmic risk stratification of patients with left ventricular dysfunction

International Journal of Cardiology

Volumn 119, Issue 1, 2007, Pages 129-130

  Baravelli, Massimo ^a,b   Fantoni, Cecilia ^a,b   Anzà, Claudio ^a,b  

^a IRCCS MULTIMEDICA   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Arrhytmic risk; Implantable cardioverter defibrillator; Left ventricular dysfunction; Micro T Wave alternans; Sudden cardiac death

Indexed keywords

ARTICLE; CARDIOMYOPATHY; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MICRO T WAVE ALTERNANS; MORTALITY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; RISK ASSESSMENT; T WAVE;

EID: 34249743676     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.100     Document Type: Article

References (9)

1. Baravelli M., Salerno-Uriarte D., Guzzetti D., et al. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study. Int J Cardiol 105 1 (2005) 53-57
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 342 (2005) 225-237
4. Buxton A.E. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction ≤ 30% should receive an implantable cardioverter-defibrillator. Circulation 111 19 (2005) 2537-2549
5. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 47 (2006) 269-281
6. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
7. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 2 (2006) 456-463
8. Armoundas A.A., Hohnloser S.H., Ikeda T., and Cohen R.J. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?. Nat. Clin. Pract. 2 (2005) 522-528
9. Buxton A.E., Lee K.L., Hafley G.E., et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 106 19 (2002) 2466-2472